Beckers Hospital Review

BeckersHospitalReview.com is a news site that provides reporting on healthcare industry topics such as new studies, legal developments, executive moves, and health system financials. The site often covers emerging medical research and its implications for patients and the healthcare industry. An article published on the site reported on a study linking semaglutide, an ingredient in Ozempic and Wegovy, to a higher risk of an eye condition that can cause blindness.

78%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

95%

Examples:

  • The article suggests that patients taking semaglutide may be at higher risk of an eye condition that can cause blindness.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

100%

Examples:

No current examples available.

Deceptions

35%

Examples:

  • The study found patients taking Ozempic and Wegovy were more likely to develop non-arteritic anterior ischemic optic neuropathy, known as NAION, a condition that restricts blood flow to the optic nerve and causes sudden vision loss.

Recent Articles

  • New Study Links Semaglutide Use to Increased Risk of Optic Neuropathy: 17 Diabetes and 20 Obesity Patients Developed NAION While Taking the Drug

    New Study Links Semaglutide Use to Increased Risk of Optic Neuropathy: 17 Diabetes and 20 Obesity Patients Developed NAION While Taking the Drug

    Broke On: Wednesday, 03 July 2024 Semaglutide use linked to increased risk of vision loss, study finds, prompting caution for Ozempic and Wegovy patients.